Each case study provides key takeaways for stakeholders in universities, other public research organisations and businesses. Overall, they demonstrate the importance of patents for technology transfer to start-ups, spin-offs and established companies.
- intellectual property | technology transfer | health care industry
- Live streaming available
- European Innovation Council and SMEs Executive Agency
- Number of seats
- 1000 Participants
- Entrance fee
- This Webinar is offered free of charge
Time: 10:30 am - 12:00 pm (CEST) - the webinar session will open 15 minutes before the official start
Host: European IP Helpdesk and EPO Academy
Expert: Mustafa Çakır, Patent attorney and Co-Founder at Patent Effect
Moderator: Stephanie Weber, Communication Manager, European IP Helpdesk
Level of Expertise: Intermediate
Case: Dermis Pharma
R&D led by four female inventors from a Turkish university laboratory resulted in a product that can treat open wounds, such as diabetic ulcers. Although IP protection was secured early on with the help of the local technology transfer office, initial commercialisation attempts through licensing failed. Encouraged by their participation in a start-up acceleration programme, the female inventor team created the start-up Dermis Pharma. With the help of strong IP, the
young company was able to secure the necessary venture capital funding for cost-intensive clinical trials and product development. A corporate partnership became possible through an IP-assignment deal with a big Turkish pharma company and accelerated the commercialisation process.
- A well-defined IP policy, qualified commercialisation experts, the support of university administration and a widespread network are critical success factors for IP-based spin-off companies.
- Spin-off and corporate partnership models are attractive approaches which can be widely implemented by technology transfer offices.
- The EPO's IPscore tool makes it possible to assess, qualitatively analyse, graphically visualise and document the pros and cons of technologies and research projects.
- Involving a global IP and licensing network can provide deeper insights and novel pathways for better IP strategy and IP management facilitating commercialisation.
Fee: The webinar will be offered free of charge.
Assistance: For any technical assistance or questions, please contact the training team at: email@example.com